# Merieux Developpement: portfolio, investments and team > Merieux Developpement is a private equity based in France. 11 investments on record, latest Sept 2016. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/merieux-developpement (Millionrounds; every figure on the page links to its filing or article) France · [Investor](https://millionrounds.com/investors) # Merieux Developpement Last cheque observed Sep 2016. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Private equity Growth Seed Series A Gaming Operating Systems 🎨 Design Cheques on record **0%** of best year **0** **cheques in 12 months**, 11 on record Since the last cheque **3700** days **00** hrs **00** min **00** sec Median round **$47M** Rounds led **0 of 11** Sole investor **2 rounds** Mostly in **United States, 73%** Pitch Merieux Developpement ## Merieux Developpement highlights - 01 11 rounds on record - 02 Mostly Series B and Series C: 67% of its rounds - 03 Sole investor in 2 rounds, median $47M ## What they do - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Growth Seed Series A Series B - **Sectors:** Gaming Operating Systems 🎨 Design - **Based in:** Lyon, France - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **11 appearances** - **2016** 1 round - **Sept** **[Proclara Biosciences](https://millionrounds.com/company/proclara-biosciences)** Series E · US · FinSMEs **$47M** Sole investor - **2014** 3 rounds - **May** **[ImaginAb](https://millionrounds.com/company/imaginab)** Series B · US **$21M** With 3 others - **Apr** **[Kalila Medical](https://millionrounds.com/company/kalila-medical)** US **Undisclosed** Sole investor - **Mar** **[NeuroPhage Pharmaceuticals](https://millionrounds.com/company/neurophage-pharmaceuticals)** Series D · US **$17M** With 1 other - **2013** 2 rounds - **May** **[NeuroPhage Pharmaceuticals](https://millionrounds.com/company/neurophage-pharmaceuticals)** Growth · US · finsmes.com **$6.4M** With 1 other - **May** **[NeuroPhage Pharmaceuticals](https://millionrounds.com/company/neurophage-pharmaceuticals)** Series C · US **$6.4M** With 1 other - **2012** 3 rounds - **Oct** **[Biom'Up](https://millionrounds.com/company/biom-up)** Venture · FR · finsmes.com **$8.8M** With 3 others - **Mar** **[NeuroPhage Pharmaceuticals](https://millionrounds.com/company/neurophage-pharmaceuticals)** Series B · US · finsmes.com **$9.0M** With 2 others - **Jan** **[Amplitude](https://millionrounds.com/company/amplitude)** Series B · FR **$39M** With 3 others - **2011** 1 round - **Mar** **[NeuroPhage Pharmaceuticals](https://millionrounds.com/company/neurophage-pharmaceuticals)** Series B · US · neurophage.com **$12M** With 2 others - **2010** 1 round - **Nov** **[SuperSonic Imagine](https://millionrounds.com/company/supersonic-imagine)** Series C · FR · businesswire.com **$45M** With 7 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **4** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## The cheque Growth Seed Series A Median round joined **$47M** the round, not its cheque Alone, median **$47M** Led 0 of 11 rounds **0%** - **Sole investor:** 2 rounds - **Last cheque:** Sept 2016 Rounds by stage said on their site - Series B said *4* - Series C *2* - Growth said *1* - Series D *1* - Series E *1* - Seed said *-* - Series A said *-* Cheques by year Led Joined 2010 2016 Often in the room with - [Shire](https://millionrounds.com/fund/shire) 5 - [Auriga Partners](https://millionrounds.com/fund/auriga-partners) 2 **Pitching Merieux Developpement?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Merieux Developpement. A count of rooms they were both in, not a relationship either has claimed. [**Shire** Corporate VC **5** rounds together](https://millionrounds.com/fund/shire)[**Auriga Partners** VC firm **2** rounds together](https://millionrounds.com/fund/auriga-partners) ## Quick answers about Merieux Developpement ### What does Merieux Developpement invest in? Merieux Developpement invests most often at Series B and Series C (67% of the rounds on record), in sectors such as Gaming, Operating Systems and 🎨 Design. ### How active is Merieux Developpement? 11 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2016. ### What has Merieux Developpement invested in recently? Its most recent investments on record: Proclara Biosciences (Series E, Sept 2016). ### How big are Merieux Developpement's cheques? The median round it joins is $47M. ### Does Merieux Developpement lead rounds? Rarely, if at all: none of its 11 investments on record names it as the lead. ### Where does Merieux Developpement invest? Most of the companies it backs are in the United States (73%) and France (27%). ### Is Merieux Developpement investing now? No investments in the last 12 months; the latest was in Sept 2016. ### Who does Merieux Developpement invest alongside? Most often Shire (5 rounds together) and Auriga Partners (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=merieux-developpement) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=merieux-developpement)